Spyre Therapeutics Inc (SYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 61,253 | 55,392 | 44,147 | 47,774 | 45,914 |
| Operating Income | -61,253 | -55,392 | -44,147 | -47,774 | -45,914 |
| Other Income | 4,958 | -13,618 | 5,310 | 3,949 | -17,266 |
| Pre-tax Income | -56,295 | -69,010 | -38,837 | -43,825 | -63,180 |
| Income Tax | 1 | 18 | N/A | 32 | 14 |
| Net Income Continuous | -56,296 | -69,028 | -38,837 | -43,857 | -63,194 |
| Net Income | $-56,296 | $-69,028 | $-38,837 | $-43,857 | $-63,180 |
| EPS Basic Total Ops | -2.05 | -1.06 | -0.59 | -0.72 | -3.23 |
| EPS Basic Continuous Ops | -1.01 | -1.36 | -0.86 | -1.20 | 21.89 |
| EPS Diluted Total Ops | -2.05 | -1.06 | -0.59 | -0.72 | -3.23 |
| EPS Diluted Continuous Ops | -1.01 | -1.36 | -0.86 | -1.20 | 21.89 |
| EPS Diluted Before Non-Recurring Items | -0.81 | -1.36 | -0.86 | N/A | N/A |
| EBITDA(a) | $-61,253 | $-55,392 | $-44,147 | $-47,774 | $-45,914 |